| 生物活性 | |||
|---|---|---|---|
| 描述 | L-4-Hydroxyisoleucine (4-HIL) is a new type of insulin secretion enhancer and can be used in the treatment of type 2 diabetes. L-4-hydroxyisoleucine is a non-protein amino acid in fenugreek. This amino acid mainly exists in fenugreek seeds, accounting for about 80% of the total free amino acids in the seeds. 4-Hydroxyisoleucine (4-HIL) exhibits a unique glucose-dependent insulinotropic activity and is a promising candidate for the treatment of diabetes. Six genes involved in oxaloacetate and α-ketoglutarate branches were overexpressed or deleted, which increased the production of 4-HIL to 5.12 g/L but a considerable amount of L-isoleucine still accumulated in the culture[3]. 4-HIL significantly repressed the mRNA and protein levels of iRhom2 and TACE in RAW264.7 macrophages after LPS stimulated. Meanwhile, the levels of pro-inflammatory cytokines, including TNF-α, MCP-1, and IL-6, were substantially suppressed by 4-HIL in the co-culture system[4]. 4-HIL directly or indirectly reversed TNF-α reduced glycogen levels by inhibiting JNK and IRS-1 (Ser(307)) phosphorylation and increasing AKT (Ser(473)) and GSK-3 phosphorylation[5]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
| 1 mM 5 mM 10 mM | 6.79mL 1.36mL 0.68mL | 33.97mL 6.79mL 3.40mL | 67.95mL 13.59mL 6.79mL | 
| 参考文献 | 
|---|